Diffuse panbronchiolitis: A treatable sinobronchial disease in need of recognition in the United States

Chest

Volumn 121, Issue 2, 2002, Pages 659-661

  Krishnan, Padmanabhan ^a   Thachil, Rajeeve ^a   Gillego, Virgilio ^a  

^a State University of New York Health Science Center   (United States)

Author keywords

Diffuse panbronchiolitis; Long term low dose macrolide therapy; Sinobronchial disease

Indexed keywords

AZATHIOPRINE; ERYTHROMYCIN; PREDNISONE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHUS DISEASE; CAMBODIA; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DIAGNOSTIC VALUE; DIFFUSE PANBRONCHIOLITIS; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; LUNG FUNCTION TEST; MALE; OBSTRUCTIVE AIRWAY DISEASE; PHYSICAL EXAMINATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UNITED STATES;

EID: 0036173686     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.2.659     Document Type: Article

References (10)

1. Diffuse panbronchiolits: Diagnosis and treatment
2. Diffuse panbronchiolitis
3. Diffuse panbronchiolitis in the United States
4. Progress, treatment: Annual report on the study of diffuse interstitial lung disease; grant information
5. Diffuse panbronchiolitis
6. Diffuse panbronchiolitis: Evaluation with high resolution CT
7. Clinical effects of low dose long term erythromycin chemotherapy of diffuse panbronchiolits
8. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis
9. Long term effect of erythromycin therapy in patients with chronic pseudomonas aeruginosa infection
10. Recurrence of diffuse panbronchiolitis after lung transplantation